Report Thumbnail
Product Code IM0912207489WN
Published Date 2024/3/2
English146 PagesGlobal

Intermittent Catheters Market Report by Product (Uncoated Intermittent Catheter, Coated Intermittent Catheter), Indication (Urinary Incontinence, Surgery (Major Surgery), Spinal Cord Injury, and Others), Category (Male Length Catheter, Kids Length Catheter, Female Length Catheter), End User (Hospitals, Medical Research Centers, Ambulatory Surgical Centers), and Region 2024-2032Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IM0912207489WN◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/3/2
English 146 PagesGlobal

Intermittent Catheters Market Report by Product (Uncoated Intermittent Catheter, Coated Intermittent Catheter), Indication (Urinary Incontinence, Surgery (Major Surgery), Spinal Cord Injury, and Others), Category (Male Length Catheter, Kids Length Catheter, Female Length Catheter), End User (Hospitals, Medical Research Centers, Ambulatory Surgical Centers), and Region 2024-2032Pharmaceutical_LifeSciense Market



Abstract


Summary

The global intermittent catheters market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032. Intermittent catheterization is a procedure of inserting and removing a catheter to drain urine from a bladder. It is an effective bladder management strategy for patients with incomplete bladder emptying due to idiopathic or neurogenic detrusor overactivity (NDO) dysfunction, inflammation, neurological conditions, pharmacological agents, and physical bladder obstruction. It is easy to use and convenient while preventing a distended bladder or a urinary tract infection (UTI). Besides this, as it avoids leaking, blockage, and bladder spasms, the demand for intermittent catheters are increasing across the globe. Intermittent Catheters Market Trends: At present, there is a rise in the number of patients suffering from urinary tract infections (UTIs) and blockages in the urethra around the world. This, along with the growing incidences of tumors in the urinary tract or reproductive organs, represents one of the key factors driving the market. Moreover, the rising prevalence of urological disorders, such as cystitis, benign prostatic hyperplasia, and kidney stones, among the masses is offering lucrative growth opportunities to industry investors. Besides this, there is an increase in the demand for intermittent catheters in various medical conditions, such as spinal cord injury, multiple sclerosis, or dementia. This, coupled with the burgeoning healthcare industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce coated urine catheters with temperature monitoring for enhanced protection against secondary infections. They are also launching platforms for providing online counseling and guidance to patients who cannot visit healthcare facilities for treatment. Apart from this, the escalating demand for novel catheters, such as hydrophilic antimicrobial intermittent catheters, is bolstering the growth of the market. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global intermittent catheters market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication, category and end user. Breakup by Product: Uncoated Intermittent Catheter Coated Intermittent Catheter Antimicrobial Hydrophilic Others Breakup by Indication: Urinary Incontinence Surgery (Major Surgery) Spinal Cord Injury Others Breakup by Category: Male Length Catheter Kids Length Catheter Female Length Catheter Breakup by End User: Hospitals Medical Research Centers Ambulatory Surgical Centers Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Coloplast A/S, Cure Medical LLC (Convatec Group plc), Hollister Incorporated, Hunter Urology, Medical Technologies of Georgia Inc., Pennine Healthcare Ltd., Teleflex Inc and Wellspect Limited (Dentsply Sirona). Key Questions Answered in This Report 1. What was the size of the global intermittent catheters market in 2023? 2. What is the expected growth rate of the global intermittent catheters market during 2024-2032? 3. What are the key factors driving the global intermittent catheters market? 4. What has been the impact of COVID-19 on the global intermittent catheters market? 5. What is the breakup of the global intermittent catheters market based on the product? 6. What is the breakup of the global intermittent catheters market based on the indication? 7. What is the breakup of the global intermittent catheters market based on category? 8. What is the breakup of the global intermittent catheters market based on the end user? 9. What are the key regions in the global intermittent catheters market? 10. Who are the key players/companies in the global intermittent catheters market?

Table of Contents

  • 1 Preface

  • 2 Scope and Methodology

    • 2.1 Objectives of the Study
    • 2.2 Stakeholders
    • 2.3 Data Sources
      • 2.3.1 Primary Sources
      • 2.3.2 Secondary Sources
    • 2.4 Market Estimation
      • 2.4.1 Bottom-Up Approach
      • 2.4.2 Top-Down Approach
    • 2.5 Forecasting Methodology
  • 3 Executive Summary

  • 4 Introduction

    • 4.1 Overview
    • 4.2 Key Industry Trends
  • 5 Global Intermittent Catheters Market

    • 5.1 Market Overview
    • 5.2 Market Performance
    • 5.3 Impact of COVID-19
    • 5.4 Market Forecast
  • 6 Market Breakup by Product

    • 6.1 Uncoated Intermittent Catheter
      • 6.1.1 Market Trends
      • 6.1.2 Market Forecast
    • 6.2 Coated Intermittent Catheter
      • 6.2.1 Market Trends
      • 6.2.2 Key Segments
      • 6.2.3 Others
  • 7 Market Breakup by Indication

    • 7.1 Urinary Incontinence
      • 7.1.1 Market Trends
      • 7.1.2 Market Forecast
    • 7.2 Surgery (Major Surgery)
      • 7.2.1 Market Trends
      • 7.2.2 Market Forecast
    • 7.3 Spinal Cord Injury
      • 7.3.1 Market Trends
      • 7.3.2 Market Forecast
    • 7.4 Others
      • 7.4.1 Market Trends
      • 7.4.2 Market Forecast
  • 8 Market Breakup by Category

    • 8.1 Male Length Catheter
      • 8.1.1 Market Trends
      • 8.1.2 Market Forecast
    • 8.2 Kids Length Catheter
      • 8.2.1 Market Trends
      • 8.2.2 Market Forecast
    • 8.3 Female Length Catheter
      • 8.3.1 Market Trends
      • 8.3.2 Market Forecast
  • 9 Market Breakup by End User

    • 9.1 Hospitals
      • 9.1.1 Market Trends
      • 9.1.2 Market Forecast
    • 9.2 Medical Research Centers
      • 9.2.1 Market Trends
      • 9.2.2 Market Forecast
    • 9.3 Ambulatory Surgical Centers
      • 9.3.1 Market Trends
      • 9.3.2 Market Forecast
  • 10 Market Breakup by Region

    • 10.1 North America
      • 10.1.1 United States
        • 10.1.1.1 Market Trends
        • 10.1.1.2 Market Forecast
      • 10.1.2 Canada
        • 10.1.2.1 Market Trends
        • 10.1.2.2 Market Forecast
    • 10.2 Asia-Pacific
      • 10.2.1 China
        • 10.2.1.1 Market Trends
        • 10.2.1.2 Market Forecast
      • 10.2.2 Japan
        • 10.2.2.1 Market Trends
        • 10.2.2.2 Market Forecast
      • 10.2.3 India
        • 10.2.3.1 Market Trends
        • 10.2.3.2 Market Forecast
      • 10.2.4 South Korea
        • 10.2.4.1 Market Trends
        • 10.2.4.2 Market Forecast
      • 10.2.5 Australia
        • 10.2.5.1 Market Trends
        • 10.2.5.2 Market Forecast
      • 10.2.6 Indonesia
        • 10.2.6.1 Market Trends
        • 10.2.6.2 Market Forecast
      • 10.2.7 Others
        • 10.2.7.1 Market Trends
        • 10.2.7.2 Market Forecast
    • 10.3 Europe
      • 10.3.1 Germany
        • 10.3.1.1 Market Trends
        • 10.3.1.2 Market Forecast
      • 10.3.2 France
        • 10.3.2.1 Market Trends
        • 10.3.2.2 Market Forecast
      • 10.3.3 United Kingdom
        • 10.3.3.1 Market Trends
        • 10.3.3.2 Market Forecast
      • 10.3.4 Italy
        • 10.3.4.1 Market Trends
        • 10.3.4.2 Market Forecast
      • 10.3.5 Spain
        • 10.3.5.1 Market Trends
        • 10.3.5.2 Market Forecast
      • 10.3.6 Russia
        • 10.3.6.1 Market Trends
        • 10.3.6.2 Market Forecast
      • 10.3.7 Others
        • 10.3.7.1 Market Trends
        • 10.3.7.2 Market Forecast
    • 10.4 Latin America
      • 10.4.1 Brazil
        • 10.4.1.1 Market Trends
        • 10.4.1.2 Market Forecast
      • 10.4.2 Mexico
        • 10.4.2.1 Market Trends
        • 10.4.2.2 Market Forecast
      • 10.4.3 Others
        • 10.4.3.1 Market Trends
        • 10.4.3.2 Market Forecast
    • 10.5 Middle East and Africa
      • 10.5.1 Market Trends
      • 10.5.2 Market Breakup by Country
      • 10.5.3 Market Forecast
  • 11 SWOT Analysis

    • 11.1 Overview
    • 11.2 Strengths
    • 11.3 Weaknesses
    • 11.4 Opportunities
    • 11.5 Threats
  • 12 Value Chain Analysis

  • 13 Porters Five Forces Analysis

    • 13.1 Overview
    • 13.2 Bargaining Power of Buyers
    • 13.3 Bargaining Power of Suppliers
    • 13.4 Degree of Competition
    • 13.5 Threat of New Entrants
    • 13.6 Threat of Substitutes
  • 14 Price Analysis

  • 15 Competitive Landscape

    • 15.1 Market Structure
    • 15.2 Key Players
    • 15.3 Profiles of Key Players
      • 15.3.1 B. Braun Melsungen AG
        • 15.3.1.1 Company Overview
        • 15.3.1.2 Product Portfolio
      • 15.3.2 Becton Dickinson and Company
        • 15.3.2.1 Company Overview
        • 15.3.2.2 Product Portfolio
        • 15.3.2.3 Financials
        • 15.3.2.4 SWOT Analysis
      • 15.3.3 Coloplast A/S
        • 15.3.3.1 Company Overview
        • 15.3.3.2 Product Portfolio
        • 15.3.3.3 Financials
        • 15.3.3.4 SWOT Analysis
      • 15.3.4 Cure Medical LLC (Convatec Group plc)
        • 15.3.4.1 Company Overview
        • 15.3.4.2 Product Portfolio
      • 15.3.5 Hollister Incorporated
        • 15.3.5.1 Company Overview
        • 15.3.5.2 Product Portfolio
        • 15.3.5.3 SWOT Analysis
      • 15.3.6 Hunter Urology
        • 15.3.6.1 Company Overview
        • 15.3.6.2 Product Portfolio
      • 15.3.7 Medical Technologies of Georgia Inc
        • 15.3.7.1 Company Overview
        • 15.3.7.2 Product Portfolio
      • 15.3.8 Pennine Healthcare Ltd
        • 15.3.8.1 Company Overview
        • 15.3.8.2 Product Portfolio
      • 15.3.9 Teleflex Inc
        • 15.3.9.1 Company Overview
        • 15.3.9.2 Product Portfolio
        • 15.3.9.3 Financials
        • 15.3.9.4 SWOT Analysis
      • 15.3.10 Wellspect Limited (Dentsply Sirona)
        • 15.3.10.1 Company Overview
        • 15.3.10.2 Product Portfolio
USD 5,399 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.